Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

From 2002 to 2003, a global pandemic of severe acute respiratory syndrome (SARS) spread to 5 continents and caused 8000 respiratory infections and 800 deaths. To ameliorate the effects of future outbreaks as well as to prepare for biodefense, a process for the production of a recombinant protein vac...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Pharm Sci
المؤلفون الرئيسيون: Chen, Wen-Hsiang, Chag, Shivali M., Poongavanam, Mohan V., Biter, Amadeo B., Ewere, Ebe A., Rezende, Wanderson, Seid, Christopher A., Hudspeth, Elissa M., Pollet, Jeroen, McAtee, C. Patrick, Strych, Ulrich, Bottazzi, Maria Elena, Hotez, Peter J.
التنسيق: Artigo
اللغة:Inglês
منشور في: The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. 2017
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612335/
https://ncbi.nlm.nih.gov/pubmed/28456726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2017.04.037
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة